Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. TGT

Go back to Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook

Quest Diagnostics (DGX) PT Raised to $160 at Jefferies

July 23, 2021 8:44 AM EDT

Jefferies analyst Brian Tanquilut raised the price target on Quest Diagnostics (NYSE: DGX) to $160.00 (from $155.00) while maintaining a Buy rating.

The analyst commented, "e are positive on DGX given our view that continued improvement in core fundamentals -- driven by accelerating payor-driven... More